FDA moves toward easing restrictions on certain peptides BioPharma Dive Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and The Unregulated World of Peptides: A Legal Minefield for Providers Holt Law